HI
Last reporting period 31 Dec, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
5.613
Exchange
XLON - London Stock Exchange
18 %
Last period Average growth rate (5y)
138%
Average growth rate (5y) has increased in 5 years
What is Average growth rate (5y) ?
An indicator of the average growth rate of the company's profit relative to the same periods of previous years in a long-term retrospective.
See also Hikma Pharmaceuticals
Company Analysis
HIK.L valuation, rating, competitors, insights and company profile
Eyestock Rating
HIK.L financial analysis by Eyestock methodology
Valuation
HIK.L valuation using historical relative method
Statements
HIK.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
HIK.L dividend yield and annual dividend
An indicator of the average growth rate of the company's profit relative to the same periods of previous years in a long-term retrospective.
Hikma Pharmaceuticals`s Average growth rate (5y) for the period ended 2023-12-31 is 18 %
